KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLand & ImprovementsLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stryker (SYK) Cash & Equivalents (2016 - 2025)

Stryker (SYK) has disclosed Cash & Equivalents for 17 consecutive years, with $4.0 billion as the latest value for Q4 2025.

  • On a quarterly basis, Cash & Equivalents rose 9.83% to $4.0 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $4.0 billion, a 9.83% increase, with the full-year FY2025 number at $4.0 billion, up 9.83% from a year prior.
  • Cash & Equivalents was $4.0 billion for Q4 2025 at Stryker, up from $3.3 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $4.0 billion in Q4 2025 to a low of $1.0 billion in Q2 2022.
  • A 5-year average of $2.4 billion and a median of $2.3 billion in 2021 define the central range for Cash & Equivalents.
  • Peak YoY movement for Cash & Equivalents: tumbled 65.73% in 2021, then surged 106.99% in 2024.
  • Stryker's Cash & Equivalents stood at $2.9 billion in 2021, then crashed by 37.36% to $1.8 billion in 2022, then skyrocketed by 61.12% to $3.0 billion in 2023, then grew by 22.92% to $3.7 billion in 2024, then rose by 9.83% to $4.0 billion in 2025.
  • Per Business Quant, the three most recent readings for SYK's Cash & Equivalents are $4.0 billion (Q4 2025), $3.3 billion (Q3 2025), and $2.4 billion (Q2 2025).